Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs NetEase Inc (NTES) Price & Performance

Gilead Sciences, Inc.Trade
NetEase IncTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs NetEase Inc — how do they compare? Gilead Sciences, Inc. trades at $135.34 (market cap $168.35B), while NetEase Inc trades at $123.19 (market cap $82.75B). The key difference: Gilead Sciences, Inc. is far larger — about 2× NetEase Inc's market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.

GILDNTES
Market Cap
$168.35B$82.75B
Sector
HealthMedia
52-Week High
$155.80$159.34
52-Week Low
$110.56$109.26
Enterprise Value
$191.42B$59.05B
Dividend Yield
2.42%2.36%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About NetEase Inc

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

Read more on NTES